Zimmer Biomet Holdings, Inc. (ZBH) Stock Price, News, Quote & History - Yahoo Finance (2024)

0&&s)if(o){var r,a=(r=e.newCount)>99;s.textContent=a?"99+":r+"",null===(t=s.parentElement)||void 0===t||t.classList.add(zt)}else s.style.display="block"},m=function(){d.refreshPanel().then(h).then(ee).catch((function(){}))};e.addEventListener("close-all-menus",(function(){xe(c)||u()})),c&&(m(),setInterval((function(){m()}),3e5),o?l&&l.addEventListener("mouseenter",(function(){p(),null==t||t.show()})):c.addEventListener("mouseenter",(function(){p(),null==t||t.show()})),c.addEventListener("mouseleave",(function(){u(),null==t||t.hide()}))),e.addElementListener(i,"click",(function(){Q("ybar","notification","",{elm:"btn",elmt:"block"===(null==s?void 0:s.style.display)?"newalert":"",subsec:"notification",itc:"1"})})),r&&Ee(e,r,"ybar","notification",{elm:"expand",subsec:"notifications",itc:"2"}),e.addElementListener(a,"focusin",(function(){i&&(i.checked=!0),null==a||a.classList.add("ybarMenuOpen")})),e.addElementListener(a,"focusout",u),e.addElementListener(n.tooltipContainer,"focusin",(function(){null==t||t.show()})),e.addElementListener(n.tooltipContainer,"focusout",(function(){null==t||t.hide()}));var f=e.getConfig().device,v=document.getElementById("ybar");v&&v.classList.contains("ybar-ytheme-crunch")&&(Qt=0);var y=new RegExp("[?&]notifications=1(&|#|$)");"desktop"===f&&i&&y.test(window.location.search)&&(i.checked=!0)};ye("ybar-mod-notification",(function(e){var n={isUH3:"crunch"===e.getConfig().ytheme,notifContainer:document.getElementById("notification-container"),notifBadge:document.getElementById("notif-badge"),notifMenu:document.getElementById("ybarNotificationMenu"),notifMenuOpener:document.querySelector("#ybarNotificationMenu + label"),notifDropdown:document.getElementById("notifDropdownContainer"),tooltipContainer:document.querySelector(".".concat(Ft)),notifLabel:document.querySelector(".".concat(Gt))};no(e,n)}))}()}};

POLL Should Tesla shareholders once again bless CEO Elon Musk's pay package proposal?

NYSE - Nasdaq Real Time Price • USD

108.23 -1.00 (-0.91%)

As of 1:50 PM EDT. Market Open.

Key Events

Line

Candle

Baseline

Mountain

Bar

Advanced Chart

Loading Chart for ZBH

9/21 12:03 PM

DELL

Date
Close
Open
High
Low
Volume

• Previous Close 109.23
• Open 110.32
• Bid 108.24 x 800
• Ask 108.31 x 800
• Day's Range 108.10 - 111.00
• 52 Week Range 102.00 - 147.50
• Volume 1,131,400
• Avg. Volume 1,295,753
• Market Cap (intraday) 22.266B
• Beta (5Y Monthly) 1.02
• PE Ratio (TTM) 24.27
• EPS (TTM) 4.46
• Earnings Date Jul 30, 2024 - Aug 5, 2024
• Forward Dividend & Yield 0.96 (0.85%)
• Ex-Dividend Date Jun 26, 2024
• 1y Target Est 136.44

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

www.zimmerbiomet.com

18,000

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

More about Zimmer Biomet Holdings, Inc.

Recent News: ZBH

View More

All SEC Filings

Corporate Changes & Voting Matters

Periodic Financial Reports

Proxy Statements

Tender Offer/Acquisition Reports

Offering Registrations

See Also

Zimmer Biomet Holdings, Inc. (ZBH) Latest Stock News & Headlines - Yahoo Finance

View More

Performance Overview: ZBH

Trailing total returns as of 6/12/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ZBH

10.90%

S&P 500

13.85%

1-Year Return

ZBH

19.81%

S&P 500

26.33%

3-Year Return

ZBH

27.94%

S&P 500

27.85%

5-Year Return

ZBH

3.91%

S&P 500

88.19%

Compare To: ZBH

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

ZBHZimmer Biomet Holdings, Inc.

108.23

-0.91%

Mkt Cap 22.266B

Industry Medical Devices

SYKStryker Corporation

346.96

+0.16%

Mkt Cap 132.173B

Industry Medical Devices

ZIMVZimVie Inc.

17.00

+2.41%

Mkt Cap 463.908M

Industry Medical Devices

26.08

+1.14%

Mkt Cap 11.742B

Industry Medical Devices

EWEdwards Lifesciences Corporation

87.98

+1.13%

Mkt Cap 53.017B

Industry Medical Devices

MDTMedtronic plc

82.62

+0.81%

Mkt Cap 108.34B

Industry Medical Devices

BIOBio-Rad Laboratories, Inc.

282.61

+0.51%

Mkt Cap 8.081B

Industry Medical Devices

MASIMasimo Corporation

130.01

+4.70%

Mkt Cap 6.902B

Industry Medical Devices

STESTERIS plc

226.14

+0.54%

Mkt Cap 22.365B

Industry Medical Devices

BSXBoston Scientific Corporation

77.34

+0.24%

Mkt Cap 113.696B

Industry Medical Devices

PENPenumbra, Inc.

193.31

+1.77%

Mkt Cap 7.494B

Industry Medical Devices

Statistics: ZBH

View More

Valuation Measures

Annual

As of 6/10/2024

• Market Cap

  23.22B

• Enterprise Value

  28.79B

• Trailing P/E

  24.49

• Forward P/E

  13.99

• PEG Ratio (5yr expected)

  1.70

• Price/Sales (ttm)

  3.16

• Price/Book (mrq)

  1.84

• Enterprise Value/Revenue

  3.86

• Enterprise Value/EBITDA

  13.34

Financial Highlights

Profitability and Income Statement

• Profit Margin

  12.93%

• Return on Assets (ttm)

  4.43%

• Return on Equity (ttm)

  7.80%

• Revenue (ttm)

  7.45B

• Net Income Avi to Common (ttm)

  963.9M

• Diluted EPS (ttm)

  4.46

Balance Sheet and Cash Flow

• Total Cash (mrq)

  393M

• Total Debt/Equity (mrq)

  47.68%

• Levered Free Cash Flow (ttm)

  1.07B

View More

Research Analysis: ZBH

View More

View More

Company Insights: ZBH

Research Reports: ZBH

View More

View More

People Also Watch

TFX Teleflex Incorporated

212.40

+2.84%

IQV IQVIA Holdings Inc.

218.06

+1.18%

COO The Cooper Companies, Inc.

95.32

+1.65%

XRAY DENTSPLY SIRONA Inc.

27.26

+1.09%

UHS Universal Health Services, Inc.

187.78

+1.13%

MTD Mettler-Toledo International Inc.

1,454.24

+0.89%

FTV Fortive Corporation

73.83

+1.36%

STE STERIS plc

226.14

+0.54%

EW Edwards Lifesciences Corporation

87.98

+1.13%

RMD ResMed Inc.

212.73

+1.21%

WAT Waters Corporation

303.80

+1.10%

HSIC Henry Schein, Inc.

66.76

+0.37%

SYK Stryker Corporation

346.96

+0.16%

ZTS Zoetis Inc.

175.54

-1.68%

VRSK Verisk Analytics, Inc.

263.70

-0.37%

ALLE Allegion plc

120.21

+2.47%